(MedPage Today) -- The recent fungal meningitis outbreak has put a spotlight on compounding pharmacies, and regulators and stakeholders say Congress needs to clarify exactly who should regulate these entities. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment